E-ISSN 2149-388X | ISSN 2149-0430
 

Original Article 


Dosimetric Comparison of Scalp Protection in Whole Brain Radiotherapy Due to Brain Metastasis

Mehmet Demirtas, Suheyla Aytac Arslan.

Abstract
Introduction: The objective is to demonstrate dosimetrically preserving scalp in whole-brain irradiation in the treatment of brain metastases and making dosimetry at 20 points determined on the rando phantom while comparing between Linac and Tomotherapy devices.
Materials and Methods: 10 randomized patients, who had previously undergone radiotherapy for whole-brain metastasis cancer, were determined prospectively. In Helical Tomotherapy (HT) and Linac devices, Intensity-modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT) were planned to be 30 Gray(Gy) 10 Fractions for the whole brain region.
Results: The average target volume (PTV), Homogeneity Index (HI), conformity index (CI), and integral dose (ID) for IMRT and VMAT were 0.075, 0.77, 0.94, 0.97 and 29.67, 23.57, respectively. Mean median doses for scalp IMRT and VMAT were 19.71Gy and 18.01 Gy (p<0.005). Lenses and body doses were significant for IMRT and VMAT. The mean median plan doses for Rando phantom scalp were 19.43Gy and 19.55Gy in IMRT and VMAT, respectively. The mean median film doses for Rando phantom scalp were 17.03Gy and 20.64Gy in IMRT and VMAT, respectively (p<0.005).
Conclusion: By using both VMAT and Helical Tomotherapy techniques, it is possible to dry the lens and scalp without low PTV doses in whole-brain irradiation.

Key words: Brain metastasis, Scalp, Intensity-Modulated Radiotherapy, Volumetric Modulated Arc Therapy, Helical Tomotherapy


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Mehmet Demirtas
Articles by Suheyla Aytac Arslan
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Demirtas M, Arslan SA. Dosimetric Comparison of Scalp Protection in Whole Brain Radiotherapy Due to Brain Metastasis. Ulutas Med J. 2021; 7(2): 69-76. doi:10.5455/umj.20210510081414.Online


Web Style

Demirtas M, Arslan SA. Dosimetric Comparison of Scalp Protection in Whole Brain Radiotherapy Due to Brain Metastasis. https://www.ulutasmedicaljournal.com/?mno=80412 [Access: June 14, 2022]. doi:10.5455/umj.20210510081414.Online


AMA (American Medical Association) Style

Demirtas M, Arslan SA. Dosimetric Comparison of Scalp Protection in Whole Brain Radiotherapy Due to Brain Metastasis. Ulutas Med J. 2021; 7(2): 69-76. doi:10.5455/umj.20210510081414.Online



Vancouver/ICMJE Style

Demirtas M, Arslan SA. Dosimetric Comparison of Scalp Protection in Whole Brain Radiotherapy Due to Brain Metastasis. Ulutas Med J. (2021), [cited June 14, 2022]; 7(2): 69-76. doi:10.5455/umj.20210510081414.Online



Harvard Style

Demirtas, M. & Arslan, . S. A. (2021) Dosimetric Comparison of Scalp Protection in Whole Brain Radiotherapy Due to Brain Metastasis. Ulutas Med J, 7 (2), 69-76. doi:10.5455/umj.20210510081414.Online



Turabian Style

Demirtas, Mehmet, and Suheyla Aytac Arslan. 2021. Dosimetric Comparison of Scalp Protection in Whole Brain Radiotherapy Due to Brain Metastasis. THE ULUTAS MEDICAL JOURNAL, 7 (2), 69-76. doi:10.5455/umj.20210510081414.Online



Chicago Style

Demirtas, Mehmet, and Suheyla Aytac Arslan. "Dosimetric Comparison of Scalp Protection in Whole Brain Radiotherapy Due to Brain Metastasis." THE ULUTAS MEDICAL JOURNAL 7 (2021), 69-76. doi:10.5455/umj.20210510081414.Online



MLA (The Modern Language Association) Style

Demirtas, Mehmet, and Suheyla Aytac Arslan. "Dosimetric Comparison of Scalp Protection in Whole Brain Radiotherapy Due to Brain Metastasis." THE ULUTAS MEDICAL JOURNAL 7.2 (2021), 69-76. Print. doi:10.5455/umj.20210510081414.Online



APA (American Psychological Association) Style

Demirtas, M. & Arslan, . S. A. (2021) Dosimetric Comparison of Scalp Protection in Whole Brain Radiotherapy Due to Brain Metastasis. THE ULUTAS MEDICAL JOURNAL, 7 (2), 69-76. doi:10.5455/umj.20210510081414.Online